KEWAUNEE SCIENTIFIC CP (KEQU) Stock Price, Quote, News and Overview
NASDAQ:KEQU - Nasdaq - US4928541048 - Common Stock - Currency: USD
KEQU Quote, Performance and Key Statistics
NASDAQ:KEQU (8/15/2025, 8:00:02 PM)
54.06
-2.44 (-4.32%)
The current stock price of KEQU is 54.06 USD. In the past month the price decreased by -2.86%. In the past year, price increased by 10.37%.
KEQU Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 26.89 | 229.22B | ||
| ISRG | INTUITIVE SURGICAL INC | 59.66 | 172.16B | ||
| BSX | BOSTON SCIENTIFIC CORP | 36.46 | 152.63B | ||
| SYK | STRYKER CORP | 29.72 | 145.95B | ||
| MDT | MEDTRONIC PLC | 16.91 | 119.18B | ||
| BDX | BECTON DICKINSON AND CO | 13.73 | 56.16B | ||
| IDXX | IDEXX LABORATORIES INC | 54.19 | 52.34B | ||
| EW | EDWARDS LIFESCIENCES CORP | 30.45 | 45.95B | ||
| RMD | RESMED INC | 29.83 | 41.77B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.75 | 33.61B | ||
| DXCM | DEXCOM INC | 47.62 | 31.74B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.35 | 26.45B |
Related stock screener links
About KEQU
Company Profile
Kewaunee Scientific Corp. engages in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The company is headquartered in Statesville, North Carolina and currently employs 1,006 full-time employees. The Company’s products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, ultralow freezers, and epoxy resin work surfaces and sinks. Its segments include Domestic and International. The Domestic segment designs, manufactures, and installs scientific and technical furniture. The International segment consists of foreign subsidiaries. The firm's products are sold primarily through purchase orders and contracts submitted by customers through its dealers and its subsidiaries, and a national distributor. The company has three manufacturing facilities that are located in Statesville serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India serving the local, Asian, and African markets.
Company Info
KEWAUNEE SCIENTIFIC CP
2700 W Front St
Statesville NORTH CAROLINA 28677 US
CEO: Thomas D. Hull
Employees: 1006
Phone: 17048737202
KEWAUNEE SCIENTIFIC CP / KEQU FAQ
What is the stock price of KEWAUNEE SCIENTIFIC CP today?
The current stock price of KEQU is 54.06 USD. The price decreased by -4.32% in the last trading session.
What is the ticker symbol for KEWAUNEE SCIENTIFIC CP stock?
The exchange symbol of KEWAUNEE SCIENTIFIC CP is KEQU and it is listed on the Nasdaq exchange.
On which exchange is KEQU stock listed?
KEQU stock is listed on the Nasdaq exchange.
What is KEWAUNEE SCIENTIFIC CP worth?
KEWAUNEE SCIENTIFIC CP (KEQU) has a market capitalization of 159.48M USD. This makes KEQU a Micro Cap stock.
How many employees does KEWAUNEE SCIENTIFIC CP have?
KEWAUNEE SCIENTIFIC CP (KEQU) currently has 1006 employees.
What are the support and resistance levels for KEWAUNEE SCIENTIFIC CP (KEQU) stock?
KEWAUNEE SCIENTIFIC CP (KEQU) has a support level at 52.99 and a resistance level at 57.31. Check the full technical report for a detailed analysis of KEQU support and resistance levels.
Should I buy KEWAUNEE SCIENTIFIC CP (KEQU) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of KEQU, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of KEQU, evaluating the profitability, health, valuation and growth aspects
- KEWAUNEE SCIENTIFIC CP (KEQU) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- KEWAUNEE SCIENTIFIC CP (KEQU) Sales and EPS estimates to see what analysts future expectations are.
- KEWAUNEE SCIENTIFIC CP (KEQU) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- KEWAUNEE SCIENTIFIC CP (KEQU) Insider and Institutional Ownership to learn about the owners and their transactions.
- KEWAUNEE SCIENTIFIC CP (KEQU) Stock Chart to make your own analysis
- KEWAUNEE SCIENTIFIC CP (KEQU) Latest news and press-releases to stay up to date.
Does KEWAUNEE SCIENTIFIC CP (KEQU) stock pay dividends?
KEQU does not pay a dividend.
When does KEWAUNEE SCIENTIFIC CP (KEQU) report earnings?
KEWAUNEE SCIENTIFIC CP (KEQU) will report earnings on 2025-09-10.
What is the Price/Earnings (PE) ratio of KEWAUNEE SCIENTIFIC CP (KEQU)?
The PE ratio for KEWAUNEE SCIENTIFIC CP (KEQU) is 63.6. This is based on the reported non-GAAP earnings per share of 0.85 and the current share price of 54.06 USD. Check the full fundamental report for a full analysis of the valuation metrics for KEQU.
What is the Short Interest ratio of KEWAUNEE SCIENTIFIC CP (KEQU) stock?
The outstanding short interest for KEWAUNEE SCIENTIFIC CP (KEQU) is 2.7% of its float. Check the ownership tab for more information on the KEQU short interest.
KEQU Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to KEQU. When comparing the yearly performance of all stocks, KEQU is one of the better performing stocks in the market, outperforming 86.05% of all stocks.
KEQU Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to KEQU. KEQU has only an average score on both its financial health and profitability.
KEQU Financial Highlights
Over the last trailing twelve months KEQU reported a non-GAAP Earnings per Share(EPS) of 0.85. The EPS decreased by -39.71% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 4.74% | ||
| ROA | 5.86% | ||
| ROE | 17.69% | ||
| Debt/Equity | 0.96 |
KEQU Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to KEQU. The Buy consensus is the average rating of analysts ratings from 7 analysts.